Sign In
Buy ARGX
$844.50
+13.71 (+1.65%)
At Close: Aug 04, 2026
Are Medical Stocks Lagging Lantheus (LNTH) This Year?
01:40pm, Wednesday, 21'st Sep 2022 Zacks Investment Research
Here is how Lantheus Holdings (LNTH) and argenex SE (ARGX) have performed compared to their sector so far this year.
argenx Submits Biologics License Application to U.S. Food and Drug Administration for Subcutaneous Efgartigimod for Treatment of Generalized Myasthenia Gravis
05:00am, Wednesday, 21'st Sep 2022 GlobeNewswire Inc.
Submission package based on positive data from the Phase 3 ADAPT-SC trial demonstrating noninferiority of subcutaneous (SC) efgartigimod compared to intravenously administered VYVGART® (efgartigimod
argenx to Highlight Key Programs from Neuromuscular Franchise at Upcoming Medical Meetings
05:00am, Wednesday, 21'st Sep 2022 GlobeNewswire Inc.
Scientific presentations demonstrate argenx’s leadership in FcRn blockade and commitment to innovating for patients across multiple neuromuscular diseases
argenx Appoints Camilla Sylvest to Board of Directors
06:10pm, Thursday, 08'th Sep 2022 GlobeNewswire Inc.
September 8, 2022
Is Argenx (ARGX) Stock Outpacing Its Medical Peers This Year?
01:40pm, Monday, 05'th Sep 2022 Zacks Investment Research
Here is how argenex SE (ARGX) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.
Is Argenx (ARGX) Stock Outpacing Its Medical Peers This Year?
11:17am, Monday, 05'th Sep 2022
Here is how argenex SE (ARGX) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.
argenx to Present at Wells Fargo Healthcare Conference
05:00am, Wednesday, 31'st Aug 2022 GlobeNewswire Inc.
August 31, 2022Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today
argenx to Present at Wells Fargo Healthcare Conference
01:00am, Wednesday, 31'st Aug 2022
August 31 , 2022 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, tod
Here's Why argenex SE (ARGX) is a Great Momentum Stock to Buy
04:00pm, Tuesday, 23'rd Aug 2022 Zacks Investment Research
Does argenex SE (ARGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why argenex SE (ARGX) is a Great Momentum Stock to Buy
01:32pm, Tuesday, 23'rd Aug 2022
Does argenex SE (ARGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
01:40pm, Friday, 19'th Aug 2022 Zacks Investment Research
Here is how argenex SE (ARGX) and McKesson (MCK) have performed compared to their sector so far this year.
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
11:17am, Friday, 19'th Aug 2022
Here is how argenex SE (ARGX) and McKesson (MCK) have performed compared to their sector so far this year.
Immunovant (IMVT) Focus on Developing Autoimmune Disease Drug
02:40pm, Monday, 15'th Aug 2022 Zacks Investment Research
Immunovant (IMVT) remains focused on developing its lead pipeline candidate, batoclimab for treating several types of autoimmune diseases. The lack of other pipeline candidates remains a concern.
Best Momentum Stocks to Buy for August 3rd
02:00pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
SSB, XOM and ARGX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 3, 2022.
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
01:40pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Here is how McKesson (MCK) and argenex SE (ARGX) have performed compared to their sector so far this year.
